Company: ZCARW
Filing Date: 2025-03-28
Form Type: DRS
Source: 0001013762-25-003498
Chunk: 278

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-03-28
Form: DRS
Chunk 278
---
 per share and total underwriting discount we will pay to the underwriter assuming both no exercise and full exercise of the underwriter’s
option to purchase from us up to additional common shares at a price of $ per share or up to
Pre-Funded Warrants at a purchase price of $ per Pre-Funded Warrant and/or up to Series A Warrants
at a purchase price $0.0001 per Series A Warrant, less the underwriting discounts and commissions to cover over-allotments, if any.

|                                               |     | Per Unit  
 including 
 common    
 shares    |     | Per Unit   
 including  
 Pre-Funded 
 Warrants   |     | Total without  
 Over-Allotment 
 Option         |     | Total with     
 Over-Allotment 
 Option         |
|:----------------------------------------------|:----|:----------|:----|:-----------|:----|:---------------|:----|:---------------|
| Public offering price                         |     | $         |     | $          |     | $              |     | $              |
| Underwriting discounts and commissions (8.0%) |     | $         |     | $          |     | $              |     | $              |
| Proceeds, before expenses, to us              |     | $         |     | $          |     | $              |     | $              |

<div align='center'>161</div>

We have agreed to pay underwriter’s
out-of-pocket accountable expenses, actually incurred, including underwriter’s legal fees, up to a maximum amount of $200,000. Additionally,
we have agreed to pay the underwriter a non-accountable expense allowance equal to 1% of the gross proceeds raised in this offering.

We estimate that the total
expenses of the offering payable by us, not including the underwriting discounts and commissions, will be approximately $ . This amount
includes the underwriter’s expenses described above.

Right of First Refusal

We have agreed to grant the
underwriter, for the 2-year period following the commencement of sales in this offering, a right of first refusal to act as managing underwriter
and book runner, placement agent, or sales agent, for any and all future public or private equity, equity-linked or debt (excluding commercial
bank debt) offerings for which the Company retains the service of an underwriter, placement agent, or sales agent in connection with such
offering. In accordance with FINRA Rule 5110(g)(6),